kezar life sciences stock
Kezar has a 52-week high of. IPO Donovan Jones Mon Jun.
Pin On Finance
Learn more on KZRs analyst rating.
. At Kezar Life Sciences we are developing first-in-class small molecule therapies designed to inhibit. Get the latest Kezar Life Sciences Inc KZR detailed stock quotes. 15 2018 Kezar Life Sciences Prepares For US.
Kezar Life Sciences Inc. The price has risen in 7 of the last 10 days and is up by 6589 over the past 2 weeks. KZR Nasdaq Global Select KZR 970 -002 -02 Price as of July 26 2022.
Cash Could Represent 40 Of The Stock Price Wilsonville Capital Fri Jun. Shares of the clinical-stage biotech Kezar Life Sciences KZR -141 are soaring this morning following a positive mid-stage data readout for its lupus nephritis candidate zetomipzomib. Content From Our Affiliates Analysts Opinions Are Mixed on These Healthcare Stocks.
Kezar Life Sciences Stock Up 57. Compare with up to 5 Stocks Kezar Life Sciences News More News Seeking Alpha 1d Zacks 2d Seeking Alpha 4d RDBX KZR and DBVT are among after hour movers. Become a more powerful trader with our transparent AI stock forecasts.
Kezar Life Sciences KZR adaptive stock price forecast ideologically balanced newsMachine learning powered price prediction. Kezar Life Sciences stock has been rallying off the bottom of a steep correction but is trading just. 11 2018 1 Comment Share your.
The average twelve-month price prediction for Kezar Life Sciences is 1967 with a high price target of 2200 and a low price target of 1700. Kezar Life Sciences Inc. Stay on top with forecast.
It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. Is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco. Increase your awareness with intelligent balanced business news feed.
Real-time trade and investing ideas on Kezar Life Sciences Inc KZR from the largest community of traders and investors. Kezar Life Sciences Inc is a clinical-stage biotechnology company. According to the issued ratings of 2 analysts in the last year the consensus rating for Kezar Life Sciences stock is Buy based on the current 2 buy ratings for KZR.
Shares of NASDAQKZR opened at 1026 on Wednesday. During the day the stock fluctuated 497 from a day low at 986 to a day high of 1035. View Kezar Life Sciences Inc KZR investment stock information.
Kezar Life Sciences Inc 989 047 454 Watch. 1 day agoFollowing regulatory updates in late June the stock has caught a bid and has our attention as a life sciences play to capture near to medium. Is Kezar Life Sciences Stock A Buy.
The firm has a 50 day simple moving average of 670 and a 200 day simple moving average of 1144. The Kezar Life Sciences Inc stock price fell by -319 on the last day Monday 11th Jul 2022 from 1035 to 1002. Latest On Kezar Life Sciences Inc There is no recent news for this security.
Seeking Alpha 8d BTMD FTCI and SANA are. KZR Stock Price News Info The Motley Fool Twitter Kezar Life Sciences Inc. Kezar is a clinical-stage biopharmaceutical company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders.
Rooms Shows Rankings Earnings Newsletters Shop.
Pin On Finance
Farrington S Beach Lake Kezar Lake Favorite Places Beach